Latest accounts payable for HEXO: $28M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest accounts payable for HEXO is $28M as of April 2023. That compares with $62M in the prior-year period — down 55.0% year over year. Investors often review this figure alongside HEXO's historical trend and sector peers before judging valuation or financial health.
Over the past year, HEXO's accounts payable moved from $62M to $28M — a 55.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HEXO's operating scale or balance-sheet position.
A accounts payable figure of $28M for HEXO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting HEXO's accounts payable ($28M), review year-over-year change from $62M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack HEXO's accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.